title: Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents.
authors.affiliation: From Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Brigham and Women's Hospital, Boston, MA (C.D.Y., K.E.E.); and Department of Medicine, Division of Cardiology, Brigham and Women's Hospital and Department of Cardiology, Boston Children's Hospital, Boston, MA (A.M.V.).
authors.forename: Christina D
authors.initials: CD
authors.lastname: Yarrington
authors.affiliation: From Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Brigham and Women's Hospital, Boston, MA (C.D.Y., K.E.E.); and Department of Medicine, Division of Cardiology, Brigham and Women's Hospital and Department of Cardiology, Boston Children's Hospital, Boston, MA (A.M.V.).
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Valente
authors.affiliation: From Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Brigham and Women's Hospital, Boston, MA (C.D.Y., K.E.E.); and Department of Medicine, Division of Cardiology, Brigham and Women's Hospital and Department of Cardiology, Boston Children's Hospital, Boston, MA (A.M.V.). keconomy@partners.org.
authors.forename: Katherine E
authors.initials: KE
authors.lastname: Economy
mesh_terms: D000037:Abruptio Placentae; D000925:Anticoagulants / Q000009:adverse effects / Q000145:classification / Q000493:pharmacokinetics / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy; D015897:Comorbidity; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D005260:Female; D005317:Fetal Growth Retardation; D005333:Fetus / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006350:Heart Valve Prosthesis; D006401:Hematologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects / Q000493:pharmacokinetics; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006401:Hematologic Agents; D010975:Platelet Aggregation Inhibitors; D011310:Preservatives, Pharmaceutical
keywords: anticoagulation; pregnancy; thrombosis